Blood Transfusions in Leukemia a Deterrent to Hospice Care

December 12, 2017

(Medscape) – Patients with late-stage blood cancers use hospice less frequently than patients with solid tumors, and once they do get to hospice, their stay is much shorter, as previously reported by Medscape Medical News. One barrier to hospice use in this population is the need for blood transfusion, according to new findings presented here at the American Society of Hematology (ASH) 2017 Annual Meeting. Patients with leukemia who were transfusion dependent had a hospice stay that was about half as short as that in patients with leukemia who were not receiving blood transfusions. Those receiving transfusions had a 38% higher risk for receiving hospice care for less than 3 days.

Recommended Reading